This trial is testing a new way to give R-CHOP chemotherapy to elderly people with DLBCL. It will last 2.5 years and people may be eligible if they are aged 70-74.
- Non-Hodgkin's Lymphoma
1 Primary · 4 Secondary · Reporting Duration: up to 2 years 6 months
Side Effects for
Awards & Highlights
1 Treatment Group
Split Dose R-CHOP
1 of 1
46 Total Participants · 1 Treatment Group
Primary Treatment: Rituximab · No Placebo Group · Phase 2
Who is running the clinical trial?
Age 65+ · All Participants · 3 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
What medical ailment is Rituximab routinely used to treat?
"Rituximab is widely used to treat lung cancers, but can also be prescribed as a treatment for small cell lung cancer (sclc), thyroiditis and polyangium." - Anonymous Online Contributor
Are there still vacancies available for participation in this investigation?
"Affirmative. Per clinicaltrials.gov, this medical trial is currently recruiting participants and was first posted on February 16th 2021 with the most recent edit made October 4th 2022. The study requires 46 patients from one site to complete enrollment." - Anonymous Online Contributor
Has the Food and Drug Administration sanctioned Rituximab as a safe treatment?
"Rituximab, which is being tested in Phase 2 clinical trials, has been evaluated for its safety and received a score of 2. As yet, no data exists to support the efficacy of this drug." - Anonymous Online Contributor
What other experimental trials have utilized Rituximab?
"Presently, 1507 studies are underway researching the efficiency of Rituximab. Of these trials, 327 have passed into Phase 3 experimentation. Although most facilities conducting research on this medication are situated in Bethesda, Maryland; there exist 54 042 sites across the globe running clinical experiments with Rituximab." - Anonymous Online Contributor
How many participants has this trial recruited thus far?
"Affirmative, the clinical trial is actively searching for participants according to information on clinicaltrials.gov. It was initially posted on February 16th 2021 and most recently updated October 4th 2022. The study requires 46 volunteers from one location." - Anonymous Online Contributor